PTIX

PROTAGENIC THERAPEUTICS by Protagenic Therapeutics, Inc. (PTIX)

About PROTAGENIC THERAPEUTICS by Protagenic Therapeutics, Inc. (PTIX)

Protagenic Therapeutics, Inc. operates as a biotechnology company. The firm engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. It offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.32
52 Week Low
$0.13
Market cap
1.1M
Dividend yield
-
Volume
--
Avg. volume
818
P/E ratio
.21

PROTAGENIC THERAPEUTICS by Protagenic Therapeutics, Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.32
52 Week Low
$0.13
Market cap
1.1M
Dividend yield
-
Volume
--
Avg. volume
818
P/E ratio
.21